Cargando…
Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease
BACKGROUND: Identifying blood-based signatures of brain health and preclinical pathology may offer insights into early disease mechanisms and highlight avenues for intervention. Here, we systematically profiled associations between blood metabolites and whole-brain volume, hippocampal volume, and am...
Autores principales: | Green, Rebecca E., Lord, Jodie, Scelsi, Marzia A., Xu, Jin, Wong, Andrew, Naomi-James, Sarah, Handy, Alex, Gilchrist, Lachlan, Williams, Dylan M., Parker, Thomas D., Lane, Christopher A., Malone, Ian B., Cash, David M., Sudre, Carole H., Coath, William, Thomas, David L., Keuss, Sarah, Dobson, Richard, Legido-Quigley, Cristina, Fox, Nick C., Schott, Jonathan M., Richards, Marcus, Proitsi, Petroula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945600/ https://www.ncbi.nlm.nih.gov/pubmed/36814324 http://dx.doi.org/10.1186/s13195-023-01184-y |
Ejemplares similares
-
Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer’s disease
por: Lord, Jodie, et al.
Publicado: (2021) -
Metabolic correlates of late midlife cognitive outcomes: findings from the 1946 British Birth Cohort
por: Green, Rebecca, et al.
Publicado: (2021) -
Disentangling Independent and Mediated Causal Relationships Between Blood Metabolites, Cognitive Factors, and Alzheimer’s Disease
por: Lord, Jodie, et al.
Publicado: (2021) -
Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease
por: Handy, Alex, et al.
Publicado: (2021) -
Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort
por: Buchanan, Sarah M., et al.
Publicado: (2020)